EUVIMEDAtrasti EUVIMED
Multizentrische Studie

Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer

Claudio Coco, Paolo Delrio, Daniela Rega, Luca Emanuele Amodio iD, Salvatore Pucciarelli iD, Gaya Spolverato, Claudio Belluco, Andrea Lauretta, Gilberto Poggioli, Giuseppe Rocco, Francesco Bianco, Patrizia Marsanic and 4 more

Colorectal Disease · 2024

DOI: 10.1111/codi.16834 ↗

At a glance

Multizentrische Studie in Colorectal Disease, 2024. Written by Claudio Coco and 15 co-authors. Institution: U.O.C. Chirurgia Generale 2, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Major MEDLINE topics: Neoadjuvant Therapy, Rectal Neoplasms. Cited 3 times so far (Crossref); 34 references.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Aim

Local excision (LE) in selected cases after neoadjuvant radiochemotherapy (RCT) for locally advanced rectal cancer in clinically complete or major responders has been recently reported as an alternative to standard radical resection. Completion total mesorectal excision (cTME) is generally performed when high‐risk pathological features are found in LE surgical specimens. The aim of this study was to evaluate the incidence of residual tumour and lymph node metastases after cTME in patients previously treated by RCT + LE. The secondary aims were to quantify the rate of postoperative morbidity and mortality and to evaluate the long‐term oncological outcome of this group of patients.

Methods

All patients treated from 2007 to 2020 by LE for locally advanced rectal cancer with a clinically complete or major response to RCT who had a subsequent cTME for high‐risk pathological factors (ypT >1 and/or TRG >2 and/or positive margins) were included in this multicentre retrospective study. Pathological data, postoperative short‐term morbidity (classified according to Clavien–Dindo) and mortality and oncological long‐term outcome after cTME were recorded in a database. Statistical analysis was performed using Wizard for iOS version 1.9.31.

Results

A total of 47 patients were included in the study. The rate of R0 resection was 95.7%, and a sphincter‐saving procedure was performed in 37 patients (78.7%), with a protective stoma rate of 78.4%. In 28 cases (59.6%), it was possible to perform a minimally invasive approach. A residual tumour (pT and/or pN) on cTME specimens was found in 21 cases (44.7%). The rate of lymph node metastases was 12.8%. The overall short‐term (within 30 days) postoperative morbidity was 34%, but grade >2 postoperative complications occurred in only nine patients (19.1%), with a reoperation rate of 6.4%. No short‐term postoperative deaths occurred. At a median follow‐up of 57 months (range: 21–174), the long‐term stoma‐free rate was 70.2%, and the actuarial 5‐year overall survival (OS), disease‐free survival (DFS) and local control (LC) were 86.7%, 88.9% and 95.7%, respectively.

Conclusion

When patients exhibit high‐risk pathological factors after RCT + LE, cTME should be suggested due to the high risk of residual tumour or lymph node involvement (44.7%). The results after cTME in terms of the rate of R0 resection, sphincter‐saving procedure, postoperative morbidity and mortality and long‐term oncological outcome seem to be acceptable and do not represent a contraindication to use LE as a first‐step treatment in patients with major or complete clinical response after RCT.

Subjects

MeSH terms (MEDLINE)

Neoadjuvant TherapyRectal NeoplasmsHumansLymphatic MetastasisNeoplasm, ResidualTreatment OutcomeChemoradiotherapyNeoplasm Recurrence, LocalNeoplasm Staging

Author keywords

completion total mesorectal excisionlocal excisionradiochemotherapyrectal cancerresidual cancer

Authors and institutions

  • U.O.C. Chirurgia Generale 2, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Department of Abdominal Oncology, Colorectal Surgical Oncology, Istituto nazionale Tumori - IRCCS "Fondazione G. Pascale", Naples, Italy.
  • UOC Chirurgia Generale 3, Azienda Ospedale-Università Padova, Padova, Italy.
  • Department of Surgical Oncology, CRO Aviano National Cancer Institute IRCCS, Aviano, Italy.
  • Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • General and Colorectal Surgery Unit, S. Leonardo Hospital/ASL-Na3-sud, Castellammare di Stabia, Italy.

ORCID profiles: Luca Emanuele Amodio, Salvatore Pucciarelli, Vincenzo Tondolo, Gianluca Rizzo

Cite

APA

Coco, C., Delrio, P., Rega, D., Amodio, L. E., Pucciarelli, S., Spolverato, G., Belluco, C., Lauretta, A., Poggioli, G., Rocco, G., Bianco, F., Marsanic, P., Sica, G., Tondolo, V., Rizzo, G., & Italian Society of Surgical Oncology Colorectal Cancer Network (SICO CCN) group (2024). Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer. Colorectal Disease. https://doi.org/10.1111/codi.16834

Vancouver

Coco C, Delrio P, Rega D, Amodio LE, Pucciarelli S, Spolverato G, et al. Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer. Colorectal Disease. 2024. doi:10.1111/codi.16834

BibTeX
@article{Coco2024,
  author = {Coco, Claudio and Delrio, Paolo and Rega, Daniela and Amodio, Luca Emanuele and Pucciarelli, Salvatore and Spolverato, Gaya and Belluco, Claudio and Lauretta, Andrea and Poggioli, Gilberto and Rocco, Giuseppe and Bianco, Francesco and Marsanic, Patrizia and Sica, Giuseppe and Tondolo, Vincenzo and Rizzo, Gianluca and Italian Society of Surgical Oncology Colorectal Cancer Network (SICO CCN) group, Italian Society of Surgical Oncology Colorectal Cancer Network (SICO CCN) group},
  title = {Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer},
  journal = {Colorectal Disease},
  year = {2024},
  doi = {10.1111/codi.16834}
}
Start for free →